DisclosureWe earn commission on partner links; ranking is set by our published methodology — not advertisers.
An independent, side-by-side comparison of two GLP‑1 telehealth providers on price, insurance handling, drug format, and clinical depth — scored on our published scorecard, with no paid placement.
Emerald marks the stronger value where the dataset makes one objective (lower starting price, higher editorial score).
| Attribute | Form Health | Noom Med |
|---|---|---|
| Editorial score | 9.2/10 | 8.0/10 |
| Monthly from | $99/mo | $149/mo |
| Best for | Insurance handling and long-term outcomes | Psychology-led behavior change |
| Drug format | Brand-name | Brand-name · Compounded |
| Insurance handling | Handled (incl. prior auth) | Cash-pay |
| Consult type | Synchronous video | Asynchronous chat |
| Drugs covered | Wegovy, Zepbound, Ozempic, Mounjaro | Wegovy, Zepbound, Saxenda |
Best for insurance handling and long-term outcomes. From $99/mo.
Visit Form Health →Read full reviewBest for psychology-led behavior change. From $149/mo.
Visit Noom Med →Read full reviewBuilt around medical depth. Best for patients with commercial insurance who want a team that fights insurance battles and treats GLP-1 as part of a comprehensive obesity care plan.
Behavior change app expanding into medication. Strongest fit for patients who already use Noom or believe psychology-led behavior support pairs well with GLP-1 effects.
Affiliate disclosure: both "Visit" links are sponsored and we may earn a referral commission. The comparison, scores, and ordering are set by our published methodology, not by commission rates. Editorial guidance, not medical advice.